STOCK TITAN

GENWORTH FINANCIAL (GNW) SEC Filings, Jul-Oct 2025

GNW NYSE

Genworth Financial, Inc. filings document formal earnings disclosures for an insurance holding company with Enact mortgage insurance operations and a Closed Block of long-term care insurance, life insurance and annuity products. Recent Form 8-K reports furnish quarterly results press releases and financial supplements under Item 2.02.

The filings also record Genworth’s references to Enact Holdings as a publicly traded subsidiary, segment-level reporting context, conference-call notices and exhibit-based financial materials. These disclosures connect reported results to mortgage insurance performance, legacy insurance liabilities, investment impacts and holding-company capital actions.

Rhea-AI Summary

Genworth Financial Inc. filed a Form 13F reporting its institutional holdings. The report lists 2 holdings with a combined reported market value of $437,197,934. The filing was signed by Darren W. Woodell, Vice President and Controller, on 10-27-2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.64%
Tags
other
-
Rhea-AI Summary

Genworth Financial insider transaction: Rohit Gupta, identified as an officer (President & CEO, Enact) of Genworth Financial, sold 86,406 shares of Genworth common stock on 08/27/2025 at a weighted average sales price of $8.6784 per share. After the sale, Mr. Gupta directly beneficially owned 794,630 shares. In addition, 7,054.809 shares are reported as indirectly owned via a 401(k) plan. The Form 4 was signed by a power of attorney on 08/29/2025. The filer discloses the sale price range ($8.67 to $8.69) and offers to provide a detailed allocation of shares sold at each price on request.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.28%
Tags
insider
-
Rhea-AI Summary

Genworth Financial (GNW) filed an amended Rule 144 notice reporting a proposed sale of 86,406 common shares through J.P. Morgan Securities LLC, with an aggregate market value of $749,140. The shares represent part of the filer’s compensation: 59,080 shares were acquired on 03/25/2024 and 27,326 shares on 03/01/2024. The filing lists the approximate sale date as 08/27/2025 and reports 410,433,925 shares outstanding. The filer certifies no undisclosed material adverse information and provides standard Rule 144 representations.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.04%
Tags
other
Rhea-AI Summary

Donald Smith & Co., Inc. filed a Schedule 13G reporting aggregate beneficial ownership of 26,198,280 shares of Genworth Financial, Inc. (GNW), representing 6.32% of the class. The filing attributes most holdings to Donald Smith & Co., Inc. with 25,454,680 shares subject to sole voting power and 25,952,450 shares subject to sole dispositive power; DSCO Value Fund, L.P. holds 245,830 shares. The filing identifies Donald Smith & Co., Inc. as an investment adviser organized in Delaware and states the securities are held in the ordinary course of business on behalf of institutional clients, with no single client owning more than 5% of the class. The certification affirms the holdings were not acquired to influence control.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.57%
Tags
other
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.13%
Tags
quarterly report
-
13F-HR
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.08%
Tags
other
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.76%
Tags
insider

FAQ

How many GENWORTH FINANCIAL (GNW) SEC filings are available on StockTitan?

StockTitan tracks 87 SEC filings for GENWORTH FINANCIAL (GNW), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for GENWORTH FINANCIAL (GNW)?

The most recent SEC filing for GENWORTH FINANCIAL (GNW) was filed on October 27, 2025.